Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.76 USD | -2.07% | -8.69% | -28.89% |
09-03 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday | MT |
09-03 | Transcript : Arrowhead Pharmaceuticals, Inc. - Shareholder/Analyst Call |
EPS & Dividend: Arrowhead Pharmaceuticals, Inc.
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | 0.69 | -0.84 | -1.36 | -1.67 | -1.92 | -4.519 | -4.071 | -3.531 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 28.18 | 43.06 | 62.43 | 33.05 | 26.87 | 21.76 | 21.76 | 21.76 |
Nbr of stocks (in thousands) | 95,301 | 102,292 | 104,259 | 105,849 | 107,193 | 124,315 | - | - |
Announcement Date | 25/11/19 | 23/11/20 | 22/11/21 | 28/11/22 | 29/11/23 | - | - | - |
Upcoming events: Arrowhead Pharmaceuticals, Inc.
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
-.--% | -.--% | -4.82x | 20.74 | 40.94x | ||
-.--% | -.--% | 30.77x | 4.228 | 8.08x | ||
-.--% | -.--% | -237.72x | 7.407 | 10.39x | ||
-.--% | -.--% | -541.56x | 7.572 | 14.9x | ||
-.--% | -.--% | -41.18x | 1.111 | 3.33x | ||
-.--% | -.--% | -31.74x | 6.165 | 5.2x | ||
-.--% | -.--% | 22.48x | 3.548 | 4.48x | ||
+2.45% | +2.67% | 12x | 1.863 | 2.61x | ||
-.--% | -.--% | -26.56x | - | - | ||
-.--% | -.--% | 70.87x | 9.715 | 6.51x | ||
Average | +0.24% | +0.27% | -74.75x | 6.93 | 10.72x | |
Weighted average by Cap. | +0.10% | +0.11% | -113.09x | 5.64 | 8.76x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition